TopDollar Investing

[zen222]

Debt-free, low-float (33m), clean shell AEPP is reverse-merging with biopharma rising star Oncolix, Inc. this month with no change to the share structure per 8K:
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12149068

Oncolix has a worldwide patent portfolio of over 30 patents.
Oncolix's flagship ovarian cancer-fighting drug Prolanta has a $3 Billion market potential.
Early funding for Prolanta came from the Susan G. Komen Foundation and the US government. More recent funding has been in the form of accredited investors, endowments and trusts, like the family trust of Ernest Mario.
Ernest Mario served as Chief Executive Officer of Glaxo Holdings, plc, based out of London, England, known today as GlaxoSmithKline NYSE:GSK.

Ernest Mario was also the Chairman and CEO of Alza Corporation, based in Palo Alto, CA, from 1993 until the company was purchased by Johnson & Johnson, Inc, NYSE: JNJ in 2001.

Some DD on Oncolix, Inc:
https://nebula.wsimg.com/f9ea3e25d6e15d3ee2d410b787195b45?AccessKeyId=D34B304F5C474C27E878&disposition=0&alloworigin=1

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=131743480